Ensysce Biosciences auditor changes to Baker Tilly after Moss Adams merger

Ensysce Biosciences, Inc.

Moss Adams merged into Baker Tilly effective June 3, 2025; Baker Tilly appointed as successor auditor.
No disagreements or reportable events with Moss Adams during fiscal years 2024 and 2023.
Moss Adams' prior audit reports included a going concern explanatory paragraph.
Company had no consultations with Baker Tilly before appointment.
Moss Adams provided a letter agreeing with the statements in the 8-K.

item 4.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.